Intraosseous infusion (IO) is the process of injecting medication, fluids, or blood products directly into the bone marrow; [1] this provides a non-collapsible entry point into the systemic venous system. [2] The intraosseous infusion technique is used to provide fluids and medication when intravenous access is not

2023年6月5日 · Intraosseous (IO) vascular access refers to the placement of a specialized hollow bore needle through the cortex of a bone into the medullary space for infusion of medical therapy and laboratory tests.

2025年3月4日 · The intraosseous (IO) device is a life-saving tool used to provide rapid vascular access in emergency situations. It is a safe and effective technique for infusing medications, fluids, and blood products in critically-ill individuals who do not have a peripheral IV line.

This topic will discuss intraosseous (IO) infusion in children and adults, including indications, contraindications, and techniques according to device. Other forms of venous access are discussed separately:

2021年7月1日 · IO placement is a safe and rapid method for obtaining parenteral access in patients with difficult venous access. The IO route is the fastest way to infuse fluids, medications, and blood products in emergency situations including cardiac resuscitation.

Intraosseous (IO) access can be obtained using manual or drill-inserted devices for insertion of specialised needles; IO access uses the medullary space as a non collapsible entry point into the systemic venous system

When IV access cannot be achieved, IO access is safe, reliable, and quick. It can be accomplished in 30 to 60 seconds and even faster with an IO gun. This is especially helpful in pediatric emergencies when time is critical.

Intraosseous (IO) cannulation or IO access is a rapid method to administer medications through the bone marrow cavity in a critically ill or an injured patient. Learn about the procedure, avoided conditions, benefits and risks.

2023年8月20日 · Intraosseous access (IO access) involves inserting a catheter into the medullary space of a long bone, providing access to the systemic vasculature. Like intravenous access, IO medications can bypass first-pass metabolism and have maximum bioavailability.

IO infusion is a rapid and safe method for obtaining parenteral access in patients with difficult venous access. Pioneered in 1922 by Drinker and colleagues [4], this access was not used to benefit peripheral IV until the 1980s.